Mycoplasma pneumoniae is a common cause of respiratory tract infections that can sometimes lead to more serious complications. It is the smallest self-replicating microorganism and depends on attachment to host cells. Symptoms typically include a gradual onset of fever, malaise, cough and sore throat. Diagnosis is made through serology tests, culture or PCR from respiratory samples. While bacterial infections are uncommon, M. pneumoniae has been associated with dermatological, hematological and neurological complications as well as triggering asthma exacerbations. Treatment involves macrolide antibiotics like azithromycin or clarithromycin.
Mycoplasma pneumoniae is a common cause of respiratory tract infections that can sometimes lead to more serious complications. It is the smallest self-replicating microorganism and depends on attachment to host cells. Symptoms typically include a gradual onset of fever, malaise, cough and sore throat. Diagnosis is made through serology tests, culture or PCR from respiratory samples. While bacterial infections are uncommon, M. pneumoniae has been associated with dermatological, hematological and neurological complications as well as triggering asthma exacerbations. Treatment involves macrolide antibiotics like azithromycin or clarithromycin.
Mycoplasma pneumoniae is a common cause of respiratory tract infections that can sometimes lead to more serious complications. It is the smallest self-replicating microorganism and depends on attachment to host cells. Symptoms typically include a gradual onset of fever, malaise, cough and sore throat. Diagnosis is made through serology tests, culture or PCR from respiratory samples. While bacterial infections are uncommon, M. pneumoniae has been associated with dermatological, hematological and neurological complications as well as triggering asthma exacerbations. Treatment involves macrolide antibiotics like azithromycin or clarithromycin.
Mycoplasmas are the smallest self-replicating biologic system; they depend on
attachment to the host cells for obtaining nutrition. They are double-stranded DNA & are fastidious in growth. Epid. M. pneumoniae infection occur worldwide and year-round. The peak age of illness is school-aged children & adolescents. Re-infection can occur but usually mild or subclinical. Transmission of infection occurs through the respiratory route by large droplet spread. M. pneumoniae may persist for years in the respiratory tract of patients with hypogammaglobulinemia (despite Rx) & it is a common infection in acute chest syndrome of SCA, but it not prevalent in patients with AIDS!. Path. M. pneumonia most commonly causes LRTI e.g. tracheobronchitis & broncho-pneumonia, although it can cause URTI e.g. pharyngitis, sinusitis, AOM, & croup. C.M. The I.P. is 2-3 wk. The onset is gradual as headache, malaise, fever, and sore throat; followed by hoarseness and cough, whereas coryza is unusual & may suggest viral etiology. The cough initially is nonproductive, but older children and adolescents may produce frothy, white sputum. The cough may followed by dyspnea if the infection is untreated. The severity of symptoms are usually greater than that suggested by physical signs, which appear later e.g. fine crackles or wheezes that are fine and resemble those of asthma and bronchiolitis. Note: M. pneumoniae may be a common trigger of wheezing in asthmatic children & may cause chronic colonization in them. Inv. CXR usually show interstitial pneumonia or bronchopneumonia, but more commonly it show unilateral, centrally dense infiltrates in the lower lobes +/_ hilar LAP. CBP; WBC count is usually normal, but ESR is usually elevated. Serology; indirect fluorescence or enzyme-linked immune assay (EIA) can detect IgM which may remain +ve for 6–12 mo after infection. 4-fold ↑ in IgG titer, by complement fixation or EIA, between acute and convalescent sera is diagnostic; whereas Cold Agglutinin is not specific & +ve in only half of cases. - 453 - Cultures of throat or sputum on specific media is also diagnostic. PCR of nasopharyngeal or throat swab. Cx. Bacterial superinfection is unusual in M. pneumonia infection, but non- respiratory Cxs may be due to direct invasion of M. pneumoniae to other organs or due to autoimmune mechanism, including:- Dermatologic; maculopapular rashes, erythema multiforme, and Stevens- Johnson syndrome. Hematologic; hemolysis may be associated with cold hemagglutinins with +ve Coombs test after 2–3 wk of the respiratory illness; thrombocytopenia and coagulation defects are rarely occur. Neurologic; meningoencephalitis, transverse myelitis, aseptic meningitis, cerebellar ataxia, Bell's palsy, deafness, brainstem syndrome, acute demyelinating encephalitis, & Guillain-Barre syndrome. They usually occur 2–3 wk after respiratory illness but may occur without it. Note: Early onset of encephalitis may be due to direct invasion, whereas delayed onset may be due to autoimmune mechanism. Concomitant viral infection may also occur. After Mycoplasma encephalitis, 20–30% of patients may have neurologic sequelae. Other rare Cxs include: myocarditis, pericarditis, rheumatic fever–like syndrome, transient monoarticular arthritis, hepatitis, pancreatitis, and protein- losing hypertrophic gastropathy. Rx. M. pneumonia is resistant to β-lactam antibiotics which act on the cell wall of bacteria (because these organisms have no cell wall); however they sensitive to Tetracyclines & Macrolides e.g. Azithromycin, 10 mg/kg on day 1 then 5 mg/kg for the following 4 days once daily; or Clarithromycin, 15 mg/kg/day ÷ 2 for 10 days orally. These antibiotics can also given as Px during outbreak of Mycoplasma infection. Corticosteroids +/_ IVIG has been used for Rx of most Cxs of Mycoplasma infection, especially the Neurologic